Gambler: If new management doesn't PR with good news before tomorrow's opening bell (think Nash 700 and/or update on survival of cancer patients), it will appear clueless right out of the chute. I would be surprised if the new team doesn't realize that. The sp needs to go up to facilitate posting the $6.5 M bond in the Amarex case before Feb 4.

There are obviously many plausible reasons for Nader's termination. Hopefully, Nader hasn't violated any regulatory rules/laws. A partnership/BO suitor may have conditioned any potential deal on Nader's removal. Perhaps he was at loggerheads with the rest of the Board over the path forward. It could also be many other things. We should learn more over time, but I see little value in pure guesswork at this time.

I'm struggling to grasp why this termination took almost 2 weeks to finalize. I would like to think that other matters have also been in play. But that get's us back to speculation again. Sooner or latter, when we add 2 plus 2, the answer will turn out to be 4. Leronlimab should eventually make that happen.